Related Experiment Video
Updated: Jun 7, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Bowel Colonization With Carbapenem-Resistant Bacteria Is Associated With Short-Term Outcomes in Patients With
Satender Pal Singh1, Vikram Bhatia1, Pratibha Kale2
1Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India.
Fecal carbapenem-resistant gram-negative bacteria (CR-GNB) colonization in acute-on-chronic liver failure (ACLF) patients is common and linked to increased infection and mortality risks. Early identification of CR-GNB in ACLF patients is crucial for better outcomes.
Area of Science:
- Hepatology
- Infectious Diseases
- Microbiology
Background:
- Bowel colonization by antimicrobial-resistant bacteria is linked to poor outcomes in cirrhosis patients.
- This association has not been previously studied in patients with acute-on-chronic liver failure (ACLF).
Purpose of the Study:
- To investigate the prevalence of fecal carbapenem-resistant gram-negative bacteria (CR-GNB) in hospitalized ACLF patients.
- To determine the impact of CR-GNB fecal carriage on short-term clinical outcomes, including infections and mortality.
Main Methods:
- 150 ACLF patients were enrolled (June 2020 - Dec 2021).
- Stool cultures were performed at baseline and every 5 days.
- Patients were followed for 60 days post-discharge.
Main Results:
- CR-GNB were isolated from 42% of ACLF patients, with E. coli and K. pneumoniae being most common.
- CR-GNB fecal carriage was associated with higher CTP, MELD, and DF scores.
- Patients with CR-GNB had a significantly higher incidence of infectious complications (57.3% vs 19.7%) and mortality (in-hospital and 60-day).
Conclusions:
- Hospitalized ACLF patients with CR-GNB in stool face a substantially elevated risk of extraintestinal infections.
- CR-GNB fecal carriage is an independent predictor of both in-hospital and 60-day mortality in ACLF patients.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

